Dexcom Newsroom

Media Inquiries

James McIntosh

619.884.2118

[email protected]

Investor Relations

Sean Christensen

[email protected]

February 2, 2021 08:00 AM PST

Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes

Dexcom, the global leader in continuous glucose monitoring for people with diabetes, debuted today its first-ever Super Bowl commercial, starring multi-platinum recording artist, actor and philanthropist Nick Jonas, who was diagnosed with Type 1 diabetes at the age of 13. The ad, which will run during Super Bowl LV on Feb. 7, 2021, calls for better care for people with diabetes who are still painfully pricking their fingers to measure their glucose levels.

April 27, 2020 08:00 AM PDT

Dexcom to Launch Patient Assistance Program for Current U.S. Customers Impacted by COVID-19 Pandemic

Dexcom announced today a new patient assistance program to aid current U.S. customers who have lost insurance due to the COVID-19 pandemic.

When the program launches for current customers who meet eligibility requirements, Dexcom will:

Enroll eligible customers in the program during the COVID-19 pandemic
Provide two 90-day supply shipments of Dexcom CGM system supplies, with each shipment including one transmitter and three boxes of three sensors
Reduce customer cost to $45 per 90-day supply shipment

April 8, 2020 11:49 AM PDT

Dexcom Continuous Glucose Monitoring Systems to be Temporarily Offered to Hospitals During COVID-19 Emergency

Dexcom announced today that due to the public health crisis of COVID-19 and the need to preserve personal protective equipment and reduce the frequency of hospital staff exposure to the coronavirus, the company is making its Dexcom G6 CGM System temporarily available for remote patient monitoring in the hospital setting. This decision was made based on feedback received from the U.S. Food and Drug Administration (FDA).

October 8, 2019 08:00 AM PDT

Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM

Dexcom, Inc. announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for healthcare professionals to use with their patients, ages two years and up.

Explore all

What is CGM?

CGM vs. BGM

MM: Benefits of CGM

Benefits of CGM

Customer Stories

Become a Dexcom Warrior

Advocacy Organizations

Contact Us

Dexcom Newsroom

Media Inquiries

James McIntosh

Investor Relations

Sean Christensen

Recent Press Releases